Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Financial Statements and Exhibits

Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Financial Statements and Exhibits
Item 9.01: Financial Statements and Exhibits

Story continues below

(d) Exhibits

EX-99.1 2 exhibit991news_release2.htm NEWS RELEASE Exhibit Exhibit 99.1FOR IMMEDIATE RELEASE     Media:Ellen Barry Investors: Lisa Capodici (614) 553-3858  (614) 757-5035 [email protected]  [email protected] Health Recommends Shareholders Reject the Below-Market Mini-Tender Offer by TRC Capital CorporationDUBLIN,…
To view the full exhibit click here

About Cardinal Health, Inc. (NYSE:CAH)

Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.

An ad to help with our costs